These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27927689)

  • 41. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.
    Chen D; Zheng XF; Yang ZY; Liu DX; Zhang GY; Jiao XL; Zhao H
    World J Gastroenterol; 2012 Mar; 18(9):915-22. PubMed ID: 22408350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment.
    Wetting HL; Hadler-Olsen E; Magnussen S; Rikardsen O; Steigen SE; Sundkvist E; Loennechen T; Kanapathippillai P; Kildalsen H; Winberg JO; Uhlin-Hansen L; Svineng G
    Am J Pathol; 2011 May; 178(5):2389-96. PubMed ID: 21514449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of the invasion and metastasis of mammary carcinoma cells by NBD peptide targeting S100A4 via the suppression of the Sp1/MMP‑14 axis.
    Takenaga K; Ochiya T; Endo H
    Int J Oncol; 2021 Mar; 58(3):397-408. PubMed ID: 33650647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
    Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
    Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of S100A4 in human pancreatic cancer is associated with invasion.
    Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
    Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.
    Zhang W; Liu Y; Wang CW
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1361-7. PubMed ID: 24867514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
    Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
    Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4.
    Hansen MT; Forst B; Cremers N; Quagliata L; Ambartsumian N; Grum-Schwensen B; Klingelhöfer J; Abdul-Al A; Herrmann P; Osterland M; Stein U; Nielsen GH; Scherer PE; Lukanidin E; Sleeman JP; Grigorian M
    Oncogene; 2015 Jan; 34(4):424-35. PubMed ID: 24469032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis.
    Jenkinson SR; Barraclough R; West CR; Rudland PS
    Br J Cancer; 2004 Jan; 90(1):253-62. PubMed ID: 14710237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change.
    Roh SA; Choi EY; Cho DH; Jang SJ; Kim SY; Kim YS; Kim JC
    J Korean Med Sci; 2010 Mar; 25(3):353-60. PubMed ID: 20191032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.
    Li N; Song MM; Chen XH; Liu LH; Li FS
    Biomed Environ Sci; 2012 Aug; 25(4):465-70. PubMed ID: 23026527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.
    Kim JH; Kim CN; Kim SY; Lee JS; Cho D; Kim JW; Yoon SY
    Oncol Rep; 2009 Jul; 22(1):41-7. PubMed ID: 19513503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients.
    Wright KL; Adams JR; Liu JC; Loch AJ; Wong RG; Jo CE; Beck LA; Santhanam DR; Weiss L; Mei X; Lane TF; Koralov SB; Done SJ; Woodgett JR; Zacksenhaus E; Hu P; Egan SE
    Cancer Res; 2015 Nov; 75(22):4960-72. PubMed ID: 26400062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
    Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
    Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
    Wang XG; Meng Q; Qi FM; Yang QF
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
    Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
    Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.